ECoG BMI for Motor and Speech Control
Status: | Recruiting |
---|---|
Conditions: | Hospital, Neurology, Neurology, ALS, Multiple Sclerosis |
Therapuetic Areas: | Neurology, Other |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 10/18/2018 |
Start Date: | August 15, 2018 |
End Date: | August 15, 2030 |
Contact: | Adelyn Tu-Chan |
Email: | adelyn.tu@ucsf.edu |
Phone: | (415) 575-0431 |
A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control
Test the feasibility of using electrocorticography (ECoG) signals to control complex devices
for motor and speech control in adults severely affected by neurological disorders.
for motor and speech control in adults severely affected by neurological disorders.
ECoG is a type of electrophysiological monitoring that uses electrodes placed directly on the
exposed surface of the brain to record electrical activity. With this ECoG-based neural
interface, study patients will undergo training and assessment of their ability to control a
wearable hand robotic exoskeleton and determine if ECoG brain signals can be used to produce
speech.
exposed surface of the brain to record electrical activity. With this ECoG-based neural
interface, study patients will undergo training and assessment of their ability to control a
wearable hand robotic exoskeleton and determine if ECoG brain signals can be used to produce
speech.
Inclusion Criteria:
1. Age > 21
2. Limited ability to use upper limbs, based on neurological examination, due to stroke,
amyotrophic lateral sclerosis (ALS), multiple sclerosis, cervical spinal cord injury,
brainstem stroke, muscular dystrophy, myopathy or severe neuropathy.
3. Disability, defined by a 4 or greater score on the Modified Rankin Scale, must be
severe enough to cause loss of independence and inability to perform activities of
daily living.
4. If stroke or spinal cord injury, at least 1 year has passed since onset of symptoms
5. Must live within a two-hour drive of UCSF
Exclusion Criteria:
1. Pregnancy or breastfeeding
2. Inability to understand and/or read English
3. Inability to give consent
4. Dementia, based on history, physical exam, and MMSE
5. Active depression (BDI > 20) or other psychiatric illness (active general anxiety
disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), or
personality disorders (e.g. multiple personality disorder, borderline personality
disorder, etc.)
6. History of suicide attempt or suicidal ideation
7. History of substance abuse
8. Co-morbidities including ongoing anticoagulation, uncontrolled hypertension, cancer,
or major organ system failure
9. Inability to comply with study follow-up visits
10. Any prior intracranial surgery
11. History of seizures
12. Immunocompromised
13. Has an active infection
14. Has a CSF drainage system or an active CSF leak
15. Requires diathermy, electroconvulsive therapy (ECT), or transcranial magnetic
stimulation (TMS) to treat a chronic condition
16. Has an implanted electronic device such as a neurostimulator, cardiac
pacemaker/defibrillator or medication pump, or presence of any head or neck metallic
foreign bodies
17. Allergies or known hypersensitivity to materials in the Blackrock NeuroPort Array
(i.e. silicone, titanium) or the PMT Subdural Cortical Electrode (silicone, platinum
iridium, nichrome)
We found this trial at
1
site
Click here to add this to my saved trials